Common Patient Concerns about the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management

Jeffrey S. Freeman; James R. Gavin; Craig W. Spellman

Common Patient Concerns about the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management

Jeffrey S. Freeman, James R. Gavin, Craig W. Spellman

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

The authors present a case of a 46-year-old woman with type 2 diabetes mellitus who has been on a treatment regimen involving diet, exercise, and metformin. After 2 years of treatment, she has a body mass index of 35 and a glycosylated hemoglobin level of 8.0%, and this level is increasing. Her physician recommends adding a glucagon-like peptide-1 (GLP-1) receptor agonist to her treatment regimen, prompting her to ask several questions. The authors present these questions along with proposed answers, highlighting the practical application of GLP-1 receptor agonists in the context of common patient concerns.

Original language	American English
Journal	Journal of the American Osteopathic Association
Volume	112
State	Published - Jan 1 2012

Keywords

blood glucose
dabetes mellitus
dose-response relationship
drug
female
glucagon
glycosylated
hemoglobin A
humans
hypoglycemic agents
middle aged
receptors
type 2

Disciplines

Endocrinology, Diabetes, and Metabolism
Medicine and Health Sciences
Osteopathic Medicine and Osteopathy

Cite this

@article{e7019b24dd3a4edabb8aef3cd253686b,

title = "Common Patient Concerns about the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management",

abstract = " The authors present a case of a 46-year-old woman with type 2 diabetes mellitus who has been on a treatment regimen involving diet, exercise, and metformin. After 2 years of treatment, she has a body mass index of 35 and a glycosylated hemoglobin level of 8.0%, and this level is increasing. Her physician recommends adding a glucagon-like peptide-1 (GLP-1) receptor agonist to her treatment regimen, prompting her to ask several questions. The authors present these questions along with proposed answers, highlighting the practical application of GLP-1 receptor agonists in the context of common patient concerns.",

keywords = "blood glucose, dabetes mellitus, dose-response relationship, drug, female, glucagon, glycosylated, hemoglobin A, humans, hypoglycemic agents, middle aged, receptors, type 2",

author = "Freeman, {Jeffrey S.} and Gavin, {James R.} and Spellman, {Craig W.}",

year = "2012",

month = jan,

day = "1",

language = "American English",

volume = "112",

journal = "Journal of the American Osteopathic Association",

}

TY - JOUR

T1 - Common Patient Concerns about the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management

AU - Freeman, Jeffrey S.

AU - Gavin, James R.

AU - Spellman, Craig W.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The authors present a case of a 46-year-old woman with type 2 diabetes mellitus who has been on a treatment regimen involving diet, exercise, and metformin. After 2 years of treatment, she has a body mass index of 35 and a glycosylated hemoglobin level of 8.0%, and this level is increasing. Her physician recommends adding a glucagon-like peptide-1 (GLP-1) receptor agonist to her treatment regimen, prompting her to ask several questions. The authors present these questions along with proposed answers, highlighting the practical application of GLP-1 receptor agonists in the context of common patient concerns.

AB - The authors present a case of a 46-year-old woman with type 2 diabetes mellitus who has been on a treatment regimen involving diet, exercise, and metformin. After 2 years of treatment, she has a body mass index of 35 and a glycosylated hemoglobin level of 8.0%, and this level is increasing. Her physician recommends adding a glucagon-like peptide-1 (GLP-1) receptor agonist to her treatment regimen, prompting her to ask several questions. The authors present these questions along with proposed answers, highlighting the practical application of GLP-1 receptor agonists in the context of common patient concerns.

KW - blood glucose

KW - dabetes mellitus

KW - dose-response relationship

KW - drug

KW - female

KW - glucagon

KW - glycosylated

KW - hemoglobin A

KW - humans

KW - hypoglycemic agents

KW - middle aged

KW - receptors

KW - type 2

UR - https://digitalcommons.pcom.edu/scholarly_papers/204

M3 - Article

VL - 112

JO - Journal of the American Osteopathic Association

JF - Journal of the American Osteopathic Association

ER -

Common Patient Concerns about the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management

Abstract

Keywords

Disciplines

Other files and links

Cite this